Cargando…

The Subcutaneous Implantable Cardioverter-Defibrillator: A Patient Perspective

The subcutaneous implantable cardioverter-defibrillator (S-ICD) is a new technology for the management of ICD patients. But what is the patients’ perspective? Previous studies on the transvenous ICD (TV-ICD) showed that device implantation is related not only to anxiety and depression because of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nesti, Martina, Russo, Vincenzo, Palamà, Zefferino, Panchetti, Luca, Garibaldi, Silvia, Startari, Umberto, Mirizzi, Gianluca, Piacenti, Marcello, Rossi, Andrea, Sciarra, Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607293/ https://www.ncbi.nlm.nih.gov/pubmed/37892812 http://dx.doi.org/10.3390/jcm12206675

Ejemplares similares

Impact of Vein of Marshall Ethanol Infusion Combined with Anatomical Ablation for the Treatment of Persistent Atrial Fibrillation: A Long-Term Follow-Up Based on Implantable Loop Recorders
por: Nesti, Martina, et al.
Publicado: (2023)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Catheter cryoablation of ventricular ectopy originating from his region
por: Rossi, Andrea, et al.
Publicado: (2020)

Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study
por: Russo, Vincenzo, et al.
Publicado: (2022)

Correction to: Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study
por: Russo, Vincenzo, et al.
Publicado: (2023)

The subcutaneous implantable cardioverter-defibrillator should be reserved for niche indications
por: Yang, Yang, et al.
Publicado: (2022)

Reverse left ventricular remodeling is more likely in non ischemic cardiomyopathy patients upgraded to biventricular stimulation after chronic right ventricular pacing
por: Morales, Maria-Aurora, et al.
Publicado: (2011)

Prognostic value of right ventricular refractory period heterogeneity in Type-1 Brugada electrocardiographic pattern
por: Rossi, Andrea, et al.
Publicado: (2022)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

Subcutaneous Implantable Cardioverter Defibrillator: Early Experience
por: Souza, Fernando Sérgio Oliva, et al.
Publicado: (2017)

The Italian subcutaneous implantable cardioverter-defibrillator survey: S-ICD, why not?
por: Botto, Giovanni Luca, et al.
Publicado: (2017)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

A novel workflow for advanced mapping of repolarization dispersion from endocardial unipolar electrograms in patients with coved-type brugada syndrome
por: Latrofa, S, et al.
Publicado: (2023)

The subcutaneous implantable cardioverter defibrillator––review of the recent data
por: Westerman, Stacy B, et al.
Publicado: (2018)

Subcutaneous Implantable Cardioverter-Defibrillator Shock: Appropriate or Inappropriate?
por: Ip, James E.
Publicado: (2017)

An “UninTENSional” Subcutaneous Implantable Cardioverter-defibrillator Shock
por: Turner, Suzette L., et al.
Publicado: (2018)

Inappropriate subcutaneous implantable cardioverter-defibrillator shocks for bradycardia
por: Chua, Kelvin C.M., et al.
Publicado: (2021)

Painful detour of subcutaneous implantable cardioverter-defibrillator lead
por: Bisson, Jasmine, et al.
Publicado: (2022)

Subcutaneous Implantable Cardioverter Defibrillator: A Contemporary Overview
por: Guarracini, Fabrizio, et al.
Publicado: (2023)

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
por: Thienel, Manuela, et al.
Publicado: (2022)

Induced atrial fibrillation during defibrillation test on implantation of subcutaneous implantable cardioverter defibrillator
por: Kim, Ki-Hun, et al.
Publicado: (2020)

Implantation of a subcutaneous implantable cardioverter-defibrillator in a patient with epicardial defibrillation patches
por: Yoshizawa, Reisuke, et al.
Publicado: (2021)

A sustained ventricular tachycardia overlooked by subcutaneous implantable cardioverter-defibrillator but recognized by co-implanted transvenous implantable cardioverter defibrillator
por: Goto, Kentaro, et al.
Publicado: (2020)

The subcutaneous implantable cardioverter-defibrillator: A tertiary center experience
por: Khazen, Cesar, et al.
Publicado: (2019)

Atrial pacing–induced oversensing in subcutaneous implantable cardioverter-defibrillator
por: Wharmby, Amy, et al.
Publicado: (2023)

Standard and extended electrocardiographic screening for the subcutaneous implantable cardioverter-defibrillator
por: Lewandowski, M, et al.
Publicado: (2023)

Comparative outcomes of subcutaneous and transvenous cardioverter-defibrillators
por: Liang, Jin-Jun, et al.
Publicado: (2019)

Intraoperative Defibrillation Testing of Subcutaneous Implantable Cardioverter‐Defibrillator Systems—A Simple Issue?
por: Frommeyer, Gerrit, et al.
Publicado: (2016)

Successful defibrillation verification in subcutaneous implantable cardioverter‐defibrillator recipients by low‐energy shocks
por: Biffi, Mauro, et al.
Publicado: (2019)

Sport Related Sudden Death: The Importance of Primary and Secondary Prevention
por: Robles, Antonio Gianluca, et al.
Publicado: (2022)

Subcutaneous Implantable Cardioverter Defibrillators: An Overview of Implantation Techniques and Clinical Outcomes
por: Al-Ghamdi, Bandar
Publicado: (2019)

Tumescent local anesthesia for subcutaneous implantable cardioverter-defibrillator implantation: An alternative for general anesthesia
por: Romero, Jorge, et al.
Publicado: (2021)

Successful defibrillation testing in patients undergoing elective subcutaneous implantable cardioverter-defibrillator generator replacement
por: de Veld, Jolien A, et al.
Publicado: (2023)

Subcutaneous Implantable Cardioverter Defibrillators Implantation Without Defibrillation Threshold Testing: A Single Center Experience
por: Al-Ghamdi, Bandar, et al.
Publicado: (2017)

Defibrillation testing during implantation of the subcutaneous implantable cardioverter-defibrillator: a necessary standard or becoming redundant?
por: van der Stuijt, W., et al.
Publicado: (2020)

Magnetic resonance imaging in patients with a subcutaneous implantable cardioverter-defibrillator
por: Keller, Jiří, et al.
Publicado: (2015)

Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience
por: Weinstock, Jonathan, et al.
Publicado: (2016)

Safety, Efficacy and Evidence Base for Use of the Subcutaneous Implantable Cardioverter Defibrillator
por: Adduci, Carmen, et al.
Publicado: (2018)

Mobile subcutaneous implantable cardioverter-defibrillator leads to oversensing and inappropriate shocks
por: Kiamanesh, Omid, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s1c4s920rgcamosijkia70ks5d